GLSI Greenwich Lifesciences, Inc.

Fundamentals / CIK 0001799788 / USD

Greenwich Lifesciences, Inc. reported $5.90M in total assets and a net loss of $24.57M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GLSI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$18.10MFY 2019 Net Income: -$3.43M2019FY 2020 Net Income: -$1.86M2020FY 2021 Net Income: -$4.57M2021FY 2022 Net Income: -$7.83M2022FY 2023 Net Income: -$8.89M2023FY 2024 Net Income: -$17.41M2024FY 2025 Net Income: -$19.36M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $17.22M $15.48M $7.70M $6.48M $3.56M $1.06M $2.61M
Total Operating Expenses $19.45M $17.64M $9.33M $8.04M $4.60M $1.86M $3.43M
Operating Income -$19.45M -$17.64M -$9.33M -$8.04M -$4.60M -$1.86M -$3.43M
Interest Income $90K $223K $436K $215K $27K $832 --
Net Income -$19.36M -$17.41M -$8.89M -$7.83M -$4.57M -$1.86M -$3.43M
Basic EPS -$1.43 -$1.34 -$0.69 -$0.61 -$0.35 -$0.20 -$1.52
Diluted EPS -$1.43 -$1.34 -$0.69 -$0.61 -$0.35 -$0.20 -$1.52
Basic Shares Outstanding 13.5M 13.0M 12.8M -- 12.9M 9.5M 2.3M
Diluted Shares Outstanding 13.5M 13.0M 12.8M 12.9M 12.9M 9.5M 2.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.45M $3.56M $5.21M $8.27M $3.27M $3.42M $2.27M $8.69M
Total Operating Expenses $5.86M $4.02M $5.73M $9.18M $3.73M $3.77M $2.77M $9.71M
Operating Income -$5.86M -$4.02M -$5.73M -$9.18M -$3.73M -$3.77M -$2.77M -$9.71M
Interest Income $47K $73K $69K $22K $23K $21K $24K $44K
Net Income -$5.81M -$3.95M -$5.66M -$9.15M -$3.71M -$3.75M -$2.74M -$9.67M
Basic EPS -$0.40 -$0.27 -$0.39 -- -$0.27 -$0.28 -$0.21 --
Diluted EPS -$0.40 -$0.27 -$0.39 -- -$0.27 -$0.28 -$0.21 --
Basic Shares Outstanding 14.7M 14.6M 14.6M -- 13.6M 13.4M 13.2M --
Diluted Shares Outstanding 14.7M 14.6M 14.6M -- 13.6M 13.4M 13.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $6.18M $4.09M $6.99M $13.47M $27.20M $28.66M $6.8K
Cash & Short-Term Investments $6.18M $4.09M $6.99M $13.47M $27.20M $28.66M $6.8K
Total Current Assets $6.18M $4.09M -- -- -- $28.66M $6.8K
Intangible Assets -- $1.8K $5.4K $9.0K $13K $16K $20K
Total Non-Current Assets $0 $1.8K -- -- -- $16K $20K
Total Assets $6.18M $4.09M $6.99M $13.48M $27.22M $28.68M $27K
Accounts Payable $4.65M $1.18M $35K -- -- -- --
Total Current Liabilities $5.82M $3.19M $294K $263K $385K $1.05M $1.38M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0
Total Liabilities $5.82M $3.19M $294K $263K $385K $1.05M $1.38M
Common Stock $14K $13K $13K $13K $13K $13K $8.5K
Retained Earnings -$87.14M -$67.78M -$50.36M -$41.47M -$33.65M -$29.08M -$27.21M
Total Stockholders' Equity $353K $909K $6.70M $13.21M $26.83M $27.63M -$1.35M
Total Equity $353K $909K $6.70M $13.21M $26.83M $27.63M -$1.35M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $5.90M $8.88M $10.51M $6.18M $3.81M $3.13M $2.75M $4.09M
Cash & Short-Term Investments $5.90M $8.88M $10.51M $6.18M $3.81M $3.13M $2.75M $4.09M
Total Current Assets $5.90M $8.88M $10.51M $6.18M -- -- -- $4.09M
Intangible Assets -- -- -- -- -- -- $876 $1.8K
Total Non-Current Assets $0 $0 $0 $0 -- -- -- $1.8K
Total Assets $5.90M $8.88M $10.51M $6.18M $3.81M $3.13M $2.75M $4.09M
Accounts Payable $6.68M $4.81M $4.29M $4.65M -- -- $1.05M $1.18M
Total Current Liabilities $7.65M $5.76M $5.24M $5.82M $1.62M $1.69M $1.44M $3.19M
Total Non-Current Liabilities $0 $0 $0 $0 $395K $835K $1.11M $0
Total Liabilities $7.65M $5.76M $5.24M $5.82M $2.02M $2.52M $2.55M $3.19M
Common Stock $15K $15K $15K $14K $14K $13K $13K $13K
Retained Earnings -$102.6M -$96.74M -$92.79M -$87.14M -$77.59M -$73.44M -$69.41M -$67.78M
Total Stockholders' Equity -$1.75M $3.12M $5.27M $353K $1.79M $604K $200K $909K
Total Equity -$1.75M $3.12M $5.27M $353K $1.79M $604K $200K $909K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$19.36M -$17.41M -$8.89M -$7.83M -$4.57M -$1.86M -$3.43M
Stock-Based Compensation $6.80M $7.25M $2.38M $1.74M $661K $678K $195K
Change in Payables $2.07M $2.55M $35K -- -$527K -$93K $393K
Operating Cash Flow -$9.91M -$7.27M -$6.48M -$6.20M -$4.29M -$1.15M -$293K
Common Stock Issued -- -- -- -- $3.11M $30.17M --
Share Repurchases -- -- -- -$7.54M -- -- --
Financing Cash Flow $12.00M $4.37M -- -$7.54M $2.84M $29.81M $215K
Net Change in Cash $2.09M -$2.90M -$6.48M -$13.74M -$1.46M $28.65M -$78K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.81M -$3.95M -$5.66M -$9.15M -$3.71M -$3.75M -$2.74M -$9.67M
Stock-Based Compensation $950K $1.48M $1.54M $2.17M $1.54M $1.54M $1.54M $5.47M
Change in Payables $1.87M $519K -$365K $3.37M -$628K -$28K -$643K $2.03M
Operating Cash Flow -$2.98M -$1.94M -$4.70M -$3.17M -$2.67M -$2.23M -$1.83M -$1.85M
Financing Cash Flow $0 $311K $9.03M $5.55M $3.35M $2.61M $492K $122K
Net Change in Cash -$2.98M -$1.63M $4.33M $2.37M $682K $375K -$1.34M -$1.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -5480.5% -1916.5% -132.7% -59.2% -17.0% -6.7% --
Return on Assets (ROA) -313.3% -425.4% -127.1% -58.1% -16.8% -6.5% -12842.8%
Current Ratio 1.06x 1.28x -- -- -- 27.41x 0.00x
Quick Ratio 1.06x 1.28x 23.74x 51.23x 70.63x 27.41x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -720.9% -422.6% -5480.5% -1109.8% -3115.6% -8821.6% -1916.5%
Return on Assets (ROA) -416.6% -253.2% -212.0% -313.3% -521.9% -602.5% -642.9% -425.4%
Current Ratio 0.77x 1.54x 2.01x 1.06x -- -- -- 1.28x
Quick Ratio 0.77x 1.54x 2.01x 1.06x 2.35x 1.85x 1.91x 1.28x
Source: SEC EDGAR CompanyFacts (CIK 0001799788) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal